RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

Latest Press Releases

RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration

Roseland, NJ – July 1, 2020 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced the official launch of its new RenovaCare R&D Innovation Center in Berlin, Germany, where the Company’s patented technologies for isolating and spraying self-donated stem cells to regenerate tissues and organs have been under development alongside new product initiatives.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company’s commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
94 Hundred Corporate Center,
9375 E Shea Blvd, Suite 107-A
Scottsdale, AZ 85260
1-888-398-0202

Sign Up for Investor Alerts